Significant overlap was seen between hypermethylated loci in WT1-mutant AML compared to that seen in TET2- and IDH1/2-mutant AML patient samples, further supporting a common oncogenic pathway involving these genes [38]. This evidence concerns the gene WT1 and acute myeloid leukemia.